Should older patients with acute myocardial infarction receive thrombolytic therapy?

Suppr

超能文献

作者信息

Williamson B D, Muller D W, Topol E J

机构信息

Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor.

出版信息

Drugs Aging. 1992 Nov-Dec;2(6):461-8. doi: 10.2165/00002512-199202060-00002.

DOI:10.2165/00002512-199202060-00002

PMID:1493350

Abstract

摘要

相似文献

Should older patients with acute myocardial infarction receive thrombolytic therapy?

Drugs Aging. 1992 Nov-Dec;2(6):461-8. doi: 10.2165/00002512-199202060-00002.

Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.链激酶溶栓治疗老年疑似急性心肌梗死患者的成本效益

N Engl J Med. 1992 Jul 2;327(1):7-13. doi: 10.1056/NEJM199207023270102.

Arch Intern Med. 1997 Apr 14;157(7):741-6.

[Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].静脉溶栓治疗老年急性心肌梗死患者的有效性和安全性：与心脏破裂的关系

J Cardiol. 1999 Mar;33(3):153-61.

Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators.急性心肌梗死溶栓治疗中的选择偏倚。SAVE研究组

JAMA. 1991;266(4):528-32.

Delays in thrombolytic therapy for acute myocardial infarction: association with mode of transportation to the hospital, age, sex, and race.急性心肌梗死溶栓治疗的延迟：与前往医院的交通方式、年龄、性别和种族的关联。

Am J Crit Care. 2001 Jan;10(1):35-42.

Thrombolytic therapy for acute myocardial infarction in older patients.老年患者急性心肌梗死的溶栓治疗

Lancet. 1996 Mar 23;347(9004):840. doi: 10.1016/s0140-6736(96)90924-1.

Expanding indications for thrombolytic therapy in acute myocardial infarction.急性心肌梗死溶栓治疗适应证的扩展

Can J Cardiol. 1993 Mar;9(2):152-4.

Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction. European Secondary Prevention Study Group.

Lancet. 1996 May 4;347(9010):1203-7.

Optimising thrombolytic therapy in elderly patients with acute myocardial infarction.优化老年急性心肌梗死患者的溶栓治疗

Drugs Aging. 1996 Jan;8(1):17-22. doi: 10.2165/00002512-199608010-00004.

引用本文的文献

Pharmacoeconomic aspects of treatment of acute myocardial infarction with thrombolytic agents.溶栓药物治疗急性心肌梗死的药物经济学方面

Pharmacoeconomics. 1993 Mar;3(3):192-204. doi: 10.2165/00019053-199303030-00003.

Thrombolytic therapy in the elderly. Pharmacoeconomic considerations.老年人的溶栓治疗。药物经济学考量。

Drugs Aging. 1996 Apr;8(4):237-44. doi: 10.2165/00002512-199608040-00002.

Alteplase. A reappraisal of its pharmacological properties and therapeutic use in acute myocardial infarction.阿替普酶。对其在急性心肌梗死中的药理特性及治疗用途的重新评估。

Drugs. 1995 Jul;50(1):102-36. doi: 10.2165/00003495-199550010-00008.

本文引用的文献

Myocardial infarction and stroke.

Neurology. 1984 Nov;34(11):1403-9. doi: 10.1212/wnl.34.11.1403.

Effect of early systemic thrombolytic therapy on left ventricular mural thrombus formation in acute anterior myocardial infarction.早期全身溶栓治疗对急性前壁心肌梗死左心室壁血栓形成的影响。

Am J Cardiol. 1984 Aug 1;54(3):261-3. doi: 10.1016/0002-9149(84)90178-4.

Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinase.接受静脉链激酶治疗的75岁及以上和75岁以下急性心肌梗死患者的死亡率和发病率

Am J Cardiol. 1987 Jan 1;59(1):1-5. doi: 10.1016/s0002-9149(87)80059-0.

Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction.与静脉注射组织型纤溶酶原激活剂治疗急性心肌梗死相关的出血并发症。

Am J Med. 1988 Sep;85(3):353-9. doi: 10.1016/0002-9343(88)90586-4.

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.心肌梗死溶栓治疗（TIMI）试验——I期：接受重组组织型纤溶酶原激活剂和链激酶治疗患者的出血表现以及血浆纤维蛋白原和纤溶系统的变化

J Am Coll Cardiol. 1988 Jan;11(1):1-11. doi: 10.1016/0735-1097(88)90158-1.

Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock.

Circulation. 1988 Dec;78(6):1345-51. doi: 10.1161/01.cir.78.6.1345.

The impact of age on the incidence and prognosis of initial acute myocardial infarction: the Worcester Heart Attack Study.

Am Heart J. 1989 Mar;117(3):543-9. doi: 10.1016/0002-8703(89)90727-8.

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).组织型纤溶酶原激活剂降低急性心肌梗死死亡率的试验。英-斯堪的纳维亚早期溶栓研究（ASSET）。

Lancet. 1988 Sep 3;2(8610):525-30. doi: 10.1016/s0140-6736(88)92656-6.

Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.17187例疑似急性心肌梗死患者静脉注射链激酶、口服阿司匹林、两者并用或两者均不用的随机试验：ISIS-2。ISIS-2（第二次心肌梗死存活国际研究）协作组

Lancet. 1988 Aug 13;2(8607):349-60.

Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).静脉溶栓治疗急性心肌梗死的有效性。意大利心肌梗死链激酶研究组（GISSI）。

Lancet. 1986 Feb 22;1(8478):397-402.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验